Pharmacy Benefits: A New Approach
- However, high-cost drugs are here to stay and more are likely to continue to launch.Actually, in 2024, just 31 products, each with net sales growth greater than $500...
- * Rising Drug Costs: High-cost drugs are a persistent issue, and new expensive drugs are continually being introduced.
Why Now is the Time to Act
The pharmacy landscape is evolving. However, high-cost drugs are here to stay and more are likely to continue to launch.Actually, in 2024, just 31 products, each with net sales growth greater than $500 million contributed an aggregate of $50 billion in pharmacy spending increase. In the meantime, state legislatures have also turned their focus on PBM reform and several…
(The text is incomplete, ending mid-sentance.)
Key takeaways from the provided text:
* Rising Drug Costs: High-cost drugs are a persistent issue, and new expensive drugs are continually being introduced.
* important Spending Increase: 31 drugs alone accounted for a $50 billion increase in pharmacy spending in 2024.
* PBM Reform Focus: State legislatures are increasingly focusing on reforming Pharmacy Benefit Managers (PBMs).